JOINT FILING AGREEMENT
QuickLinks -- Click here to rapidly navigate through this document
Exhibit 1
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the beneficial ownership of Common Shares, no par value, of AnorMED Inc. is being filed with the Securities and Exchange Commission on behalf of each of them. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Dated: October 27, 2006
| GENZYME CORPORATION | |||||
By: |
/s/ XXXXX XXXXX |
||||
| Name: | Xxxxx Xxxxx | ||||
| Title: | Chief Legal Officer and Executive Vice President, Legal and Corporate Development | ||||
DEMATAL CORP. |
|||||
By: |
/s/ XXXXX XXXXX |
||||
| Name: | Xxxxx Xxxxx | ||||
| Title: | Secretary and Director | ||||
JOINT FILING AGREEMENT
